The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment

Hepatocellular carcinoma (HCC) is one of most common cancers and the fourth leading cause of death worldwide. Commonly, HCC development occurs in a liver that is severely compromised by chronic injury or inflammation. Liver transplantation, hepatic resection, radiofrequency ablation (RFA), transcath...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Autores principales: Leone, Patrizia, Solimando, Antonio Giovanni, Fasano, Rossella, Argentiero, Antonella, Malerba, Eleonora, Buonavoglia, Alessio, Lupo, Luigi Giovanni, De Re, Valli, Silvestris, Nicola, Racanelli, Vito
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8160723/
https://ncbi.nlm.nih.gov/pubmed/34065489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050532
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares